Hancock Whitney’s Precision BioSciences DTIL Stock Holding History

Hancock Whitney’s Portfolio DTIL Stock Details DTIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-357	Closed	-$134K	–	703
2021 Q2	$134K	Buy	+357	New	+$107K	﹤0.01%	794

Other funds holding DTIL

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Hancock Whitney's DTIL Position: Q3 2021 in Review

Hancock Whitney sold out of Precision BioSciences (DTIL) in Q3 2021, closing a stake of 357 shares — an estimated $134K sold.

Hancock Whitney first reported a position in DTIL in Q2 2021 and held it in 1 quarter. The position peaked at $134K in Q2 2021. 132 funds tracked by Wall St. Rank hold DTIL as of Q3 2021.

Hancock Whitney reported no remaining Precision BioSciences position as of Q3 2021 after selling out during the quarter.
Hancock Whitney sold 357 Precision BioSciences shares in Q3 2021, an estimated $134K.
Hancock Whitney first reported a position in Precision BioSciences in Q2 2021 and held it in 1 quarter.
Hancock Whitney's Precision BioSciences position peaked at $134K in Q2 2021.
132 funds tracked by Wall St. Rank held Precision BioSciences as of Q3 2021.

Based on Hancock Whitney's 13F filing for Q3 2021, filed 4 Nov 2021.